MTOR and leukemia: The microRNA—miR-150, miR-34a, and miR-29b—have also shown significant anti-leukaemia effects by targeting wnt-signalling, mTOR signalling pathways [101], MYC [103], and Sp1/FUT4-fucosylations [106].